Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Importance of clinical research for the UK's 10-year cancer plan.
Lee RW, Danson S, Elliot M, Park EI, Pinkney TD, Shaw CE, Vimalachandran D, Maughan T, Seymour M, Corrie P, Wadsley J. Lee RW, et al. Lancet Oncol. 2022 Aug;23(8):975-978. doi: 10.1016/S1470-2045(22)00292-3. Epub 2022 Jun 9. Lancet Oncol. 2022. PMID: 35691298 Free PMC article. No abstract available.
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experience.
Cui W Dr, Yousaf N Dr, Bhosle J Dr, Minchom A Dr, Nicholson AG Prof, Ahmed M Dr, McDonald F Dr, Locke I Dr, Lee R Dr, O'Brien M Prof, Popat S Prof. Cui W Dr, et al. Cancer Treat Res Commun. 2020;25:100261. doi: 10.1016/j.ctarc.2020.100261. Epub 2020 Dec 2. Cancer Treat Res Commun. 2020. PMID: 33310368 Free PMC article.
Defining the road map to a UK national lung cancer screening programme.
O'Dowd EL, Lee RW, Akram AR, Bartlett EC, Bradley SH, Brain K, Callister MEJ, Chen Y, Devaraj A, Eccles SR, Field JK, Fox J, Grundy S, Janes SM, Ledson M, MacKean M, Mackie A, McManus KG, Murray RL, Nair A, Quaife SL, Rintoul R, Stevenson A, Summers Y, Wilkinson LS, Booton R, Baldwin DR, Crosbie P. O'Dowd EL, et al. Among authors: lee rw. Lancet Oncol. 2023 May;24(5):e207-e218. doi: 10.1016/S1470-2045(23)00104-3. Lancet Oncol. 2023. PMID: 37142382 Review.
A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Robinson EJ, Orton M, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: lee rw. EBioMedicine. 2022 Mar;77:103911. doi: 10.1016/j.ebiom.2022.103911. Epub 2022 Mar 3. EBioMedicine. 2022. PMID: 35248997 Free PMC article.
Rapid Diagnostic Centres and early cancer diagnosis.
Erridge S, Lyratzopoulos G, Renzi C, Millar A, Lee R. Erridge S, et al. Br J Gen Pract. 2021 Oct 28;71(712):487-488. doi: 10.3399/bjgp21X717413. Print 2021 Nov. Br J Gen Pract. 2021. PMID: 34711557 Free PMC article. No abstract available.
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Greenlay EJ, Orton M, Bunce C, Lunn J, Doran SJ, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: lee rw. NPJ Precis Oncol. 2022 Oct 27;6(1):77. doi: 10.1038/s41698-022-00322-3. NPJ Precis Oncol. 2022. PMID: 36302938 Free PMC article.
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.
Hindocha S, Charlton TG, Linton-Reid K, Hunter B, Chan C, Ahmed M, Greenlay EJ, Orton M, Bunce C, Lunn J, Doran SJ, Ahmad S, McDonald F, Locke I, Power D, Blackledge M, Lee RW, Aboagye EO. Hindocha S, et al. Among authors: lee rw. NPJ Precis Oncol. 2022 Nov 23;6(1):87. doi: 10.1038/s41698-022-00332-1. NPJ Precis Oncol. 2022. PMID: 36418522 Free PMC article. No abstract available.
Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation.
Bartlett EC, Kemp SV, Ridge CA, Desai SR, Mirsadraee S, Morjaria JB, Shah PL, Popat S, Nicholson AG, Rice AJ, Jordan S, Begum S, Mani A, Derbyshire J, Morris K, Chen M, Peacock C, Addis J, Martins M, Kaye SB, Padley SPG, Devaraj A; West London Lung Screening Collaboration Group. Bartlett EC, et al. Lung Cancer. 2020 Oct;148:12-19. doi: 10.1016/j.lungcan.2020.07.027. Epub 2020 Jul 31. Lung Cancer. 2020. PMID: 32771715
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W, Coupland CAC, Burchardt J, Baldwin DR; DART initiative; Gleeson FV, Hippisley-Cox J. Liao W, et al. Lancet Respir Med. 2023 Aug;11(8):685-697. doi: 10.1016/S2213-2600(23)00050-4. Epub 2023 Apr 5. Lancet Respir Med. 2023. PMID: 37030308 Free article.
501 results